When should DMARDs be used as monotherapy in RA patients? What is the optimal patient profile for combination therapy? And which biologics have been shown to be successful as monotherapy?

When should DMARDs be used as monotherapy in RA patients? What is the optimal patient profile for combination therapy? And which biologics have been shown to be successful as monotherapy?

When should DMARDs be used as monotherapy in RA patients? What is the optimal patient profile for combination therapy? How do you biomarkers to guide your decisions? And which biologics have been shown to be successful as monotherapy?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Roy Fleischmann, MD

Roy Fleischmann, MD

Clinical Professor of Medicine
University of Texas Southwestern Medical Center at Dallas
Co-Director, Division of Rheumatology
Texas Health Presbyterian Medical Center and Co-Medical Director
Metroplex Clinical Research Center